These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2820435)

  • 1. Cholinergic modulation of the content of temporal memory.
    Meck WH; Church RM
    Behav Neurosci; 1987 Aug; 101(4):457-64. PubMed ID: 2820435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory-modulatory effects of centrally acting noradrenergic drugs: possible involvement of brain cholinergic mechanisms.
    Introini-Collison IB; Baratti CM
    Behav Neural Biol; 1992 May; 57(3):248-55. PubMed ID: 1319706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective adjustment of the speed of internal clock and memory processes.
    Meck WH
    J Exp Psychol Anim Behav Process; 1983 Apr; 9(2):171-201. PubMed ID: 6842136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice.
    Baratti CM; Huygens P; Miño J; Merlo A; Gardella J
    Psychopharmacology (Berl); 1979 Jun; 64(1):85-8. PubMed ID: 113837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampus, time, and memory.
    Meck WH; Church RM; Olton DS
    Behav Neurosci; 1984 Feb; 98(1):3-22. PubMed ID: 6696797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systemically and into the cerebral ventricles.
    Brezenoff HE; Xiao YF; Vargas H
    Life Sci; 1988; 42(8):905-11. PubMed ID: 3343890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
    Hymowitz N; Brezenoff HE
    Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
    Witkin JM
    Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental catalepsy: influences of cholinergic transmission in restraint-induced catalepsy.
    Klemm WR
    Experientia; 1983 Feb; 39(2):228-30. PubMed ID: 6682048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.
    Pertwee RG; Ross TM
    Neuropharmacology; 1991 Jan; 30(1):67-71. PubMed ID: 1646420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of central cholinoceptors in Metrazol-induced convulsions.
    Rastogi SK; Puri JN; Sinha JN; Bhargava KP
    Psychopharmacology (Berl); 1979 Oct; 65(2):215-7. PubMed ID: 117491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrients that modify the speed of internal clock and memory storage processes.
    Meck WH; Church RM
    Behav Neurosci; 1987 Aug; 101(4):465-75. PubMed ID: 3651228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central cholinergic modulation of blood pressure short-term variability.
    Milutinović S; Murphy D; Japundzić-Zigon N
    Neuropharmacology; 2006 Jun; 50(7):874-83. PubMed ID: 16487550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs as research tools in psychology: cholinergic drugs and information processing.
    Warburton DM; Wesnes K
    Neuropsychobiology; 1984; 11(2):121-32. PubMed ID: 6090974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The difference in the effects of tertiary and quaternary ammonium bases (proserine, serine, methylatropine and atropine) depending on the method of administration.
    PROZOROVSKII VB
    Biull Eksp Biol Med; 1962 Mar; 52():1048-52. PubMed ID: 14038511
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood glucose and brain function: interactions with CNS cholinergic systems.
    Stone WS; Cottrill KL; Walker DL; Gold PE
    Behav Neural Biol; 1988 Nov; 50(3):325-34. PubMed ID: 3202815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Septo-hippocampal and nBM-cortical cholinergic neurones exhibit differential time-courses of activation as a function of both type and duration of spatial memory testing in mice.
    Durkin TP; Toumane A
    Behav Brain Res; 1992 Sep; 50(1-2):43-52. PubMed ID: 1333222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central cholinergic functioning and aging.
    Müller WE; Stoll L; Schubert T; Gelbmann CM
    Acta Psychiatr Scand Suppl; 1991; 366():34-9. PubMed ID: 1654728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.